EMEA and GSK address findings from the D:A:D study

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1633, 2008-01, pp. : 20-20

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

EMEA and GSK address findings from the D:A:D study

By  

Reactions Weekly, Vol. 1, Iss. 1197, 2008-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Infliximab: safety update from EMEA

By  

Inpharma, Vol. 1, Iss. 1324, 2002-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

D-Cycloserine and Cocaine Cue Reactivity: Preliminary Findings

By Price Kimber L.   McRae-Clark Aimee L.   Saladin Michael E.   Maria Megan M. Moran-Santa   DeSantis Stacia M.   Back Sudie E.   Brady Kathleen T.  

The American Journal of Drug and Alcohol Abuse, Vol. 35, Iss. 6, 2009-12 ,pp. : 434-438

Informa Healthcare

Access to resources Recommend Favorite

Effects of d-Cycloserine on Craving to Alcohol Cues in Problem Drinkers: Preliminary Findings

By Hofmann Stefan G.   Hüweler Ruth   MacKillop James   Kantak Kathleen M.  

The American Journal of Drug and Alcohol Abuse, Vol. 38, Iss. 1, 2012-01 ,pp. : 101-107

Informa Healthcare

Access to resources Recommend Favorite

Risk management plans – one year on from the EMEA guidelines

By  

Reactions Weekly, Vol. 1, Iss. 1130, 2006-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite